Tentative Program

CCR8-targeted selective Treg cell depletion induces anti-tumor immunity Sponsored by Nippon Becton Dickinson Company, Ltd.

Chair: Takuro Saito
(Osaka University, Japan)

Speaker: Naganari Ohkura
(Osaka University, Japan)

Cancer Evolution Theory and Immunotherapy
- Elucidation of the mechanism of complete cancer cure by immunotherapy - Sponsored by Eisai Co., Ltd.

Chair: Koji Tamada
(Yamaguchi University, Japan)

Speaker: Takuya Tsunoda
(Showa University, Japan)

Recent progress in CAR T cell therapy Sponsored by Gilead Sciences

Chair: Hiroyoshi Nishikawa
(Nagoya University and National Cancer Center Research Institute, Japan)

Speaker: Yuki Kagoya
(Keio University, Japan)

Current topics in cancer immunotherapy targeting suppressive immune cells Sponsored by MSD K.K.

Speaker: Kota Itahashi
(National Cancer Center Research Institute, Japan)

※This seminar is in Japanese only

Overcoming Challenges in the Discovery of KRAS Inhibitors:
Learnings from the Development of Sotorasib Sponsored by Amgen K.K.

Chair: Yoshihisa Kobayashi
(National Cancer Center Research Institute, Japan)

Speaker: Brian Lanman
(Amgen Inc., US)

Direct antitumor effects and tumor immune activation of anti-CD38 monoclonal antibody in multiple myeloma Sponsored by Janssen Pharmaceutical K.K.

Chair: Naoki Hosen
(Osaka University, Japan)

Speaker: Daisuke Ogiya
(Tokai University, Japan)

Clinical challenges of hepatocellular carcinoma; consideration of a physician in the practice Sponsored by Chugai Pharmaceutical Co., Ltd.

Chair: Takahiro Kodama
(Osaka University, Japan)

Speaker: Sadahisa Ogasawara
(Chiba University, Japan)

Treg, CTLA-4, and PD-1 in tumor immunity Sponsored by Chugai Pharmaceutical Co., Ltd.

Chair: Hiroyoshi Nishikawa
(National Cancer Center Research Institute, Japan)

Speaker: Shimon Sakaguchi
(Osaka University, Japan)

Immunotherapeutic strategy for Immune Cold Tumors in Non-Small Cell Lung Cancer Sponsored by Chugai Pharmaceutical Co., Ltd.

Chair: Kazuto Nishio
(Kindai University, Japan)

Speaker: Ichidai Tanaka
(Nagoya University Hospital, Japan)

Treatment strategy for relapsed/refractory PTCL Sponsored by NIPPON KAYAKU CO.,LTD

Chair: Mamiko Sakata-Yanagimoto
(University of Tsukuba, Japan)

Speaker: Dai Maruyama
(Japanese Foundation for Cancer Research, Japan)

※This seminar is in Japanese only

Current status and future perspective of biomarkers for treatment-free remission in CML Sponsored by Novartis Pharma K.K., Medical Affairs

Chair: Yuka Maeda
(Division of Cancer Immunology, National Cancer Center)

Speaker: Tatsuro Jo
(Japanese Red Cross Nagasaki Genbaku Hospital, Japan)

Utility of a Novel Comprehensive Genomic Profiling with a Twin DNA/RNA Panel (Todai Oncopanel) in Solid Cancers Sponsored by KONICA MINOLTA REALM, INC.

Chair: Hiroyuki Aburatani
(The University of Tokyo, Japan)

Speaker: Katsutoshi Oda
(The University of Tokyo, Japan)

Current Status and Issues of Precision Medicine for Lymphoma Sponsored by Meiji Seika Pharma Co., Ltd.

Chair: Ritsuro Suzuki
(Shimane University, Japan)

Speaker: Mamiko Sakata-Yanagimoto
(University of Tsukuba, Japan)

Gut microbiota and liver cancer Sponserd by MIYARISAN PHARMACEUTICAL CO. LTD.

Chair: Naoko Ohtani
(Osaka Metropolitan University, Japan)

Speaker: Noriho Iida
(Kanazawa University, Japan)

※This seminar is in Japanese only